Navigation Links
New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
Date:5/8/2009

PARSIPPANY, N.J., May 8 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that new data presented at the American Society of Hypertension, Inc. (ASH) Annual Scientific Meeting and Exposition (ASH 2009) in San Francisco from the BeniSILVER study found that BENICAR(R) and BENICAR HCT(R) provided a mean reduction in 24-hour ambulatory systolic blood pressure (SBP) of 25.7 mm Hg among patients with an average age of 72 years, demonstrating efficacy without compromising safety. Patients age 65 years and older also saw their 24-hour ambulatory diastolic blood pressure (DBP) drop a mean of 12.3 mm Hg. The BeniSILVER study was designed to investigate the safety and blood pressure (BP)-lowering efficacy of BENICAR and BENICAR HCT in patients age 65 and older with mild to moderate (Stage 1) or challenging (Stage 2) hypertension.

Studies have found that both the prevalence and severity of hypertension increase as people get older, making it critical to achieve strict BP control in elderly populations.(1) In fact, in 2008, the HYpertension in the Very Elderly Trial (HYVET) demonstrated that decreasing BP in the elderly can have significant benefits in reducing the incidence of heart failure, heart attack and stroke.(2) BENICAR and BENICAR HCT are indicated for the treatment of hypertension. There are no studies with either treatment demonstrating a reduction in cardiovascular events.

In the BeniSILVER study, researchers evaluated the percent of elderly patients achieving mean 24-hour ambulatory BP targets of <135/85, <130/80 and <120/80 mm Hg. ABPM is generally considered a better indicator of target organ injury than cuff measurement, since it provides a 24-hour measurement of patient BP.(3) BENICAR and BENICAR HCT were able to safely and effectively achieve a 24-hour ambulatory target blood pressure of <135/85 mm Hg in 83 percent of elderly patients (age 65 and older). In
'/>"/>

SOURCE Daiichi Sankyo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... DUBLIN and RALEIGH, N.C. ... subsidiary of Endo International plc (NASDAQ: ENDP ... BDSI ) announced today that they have ... Buccal Film to the U.S. Food and Drug Administration ... the management of pain severe enough to require daily, ...
(Date:12/22/2014)... Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), a ... blood purification technology to help fight deadly inflammation ... countries worldwide, today announced the appointment of Dr. ... as its Senior Vice President of Clinical Development, ... Di Russo is an accomplished pediatric ...
(Date:12/22/2014)... , Dec. 22, 2014 Apnea Sciences ( ... offices in Aliso Viejo , California.  ... to the tremendous growth and worldwide expansion, a new ... patented SnoreRx, the anti snore cure have exceeded our ... "We are now in 23 countries and will ...
Breaking Medicine Technology:Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... of the Creighton University School of Medicine presented a ... of Clinical Oncology (ASCO) Annual Symposium, June 5th in ... in Gynecologic Cancer Detected by an In Vitro Assay, ... Drug Response Marker test results taken in the primary ...
... Holdings Inc. ("Ore") announced today that, pursuant to the ... of Directors of Ore (the "Board") approved and authorized ... of Ore,s common stock, $0.01 par value (the "Common ... necessary to receive at least one share of post-split ...
Cached Medicine Technology:Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers 2Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011 2Ore Pharmaceutical Holdings Announces Name Change and Reverse/Forward Stock Split to be Effective June 10, 2011 3
(Date:12/26/2014)... The Biofeedback Federation of Europe annual meeting ... Rome, Italy and is hosted by the Salesian Pontifical ... a wide variety of topics such as ADHD, anxiety, ... in athletes. The scientific program will feature the latest ... allows clients to see what is going on in ...
(Date:12/26/2014)... December 26, 2014 DW-InductionHeating.com (DaWei Induction ... designing, researching and developing, producing and marketing of a ... the business announces their new series of induction ... of the company, induction brazing refers to ... special filler material and heat. The manager says that ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... 2014 When head lice hits a home ... frenzy to get rid of it while keeping it from ... Gables now have the solution right in their neighborhood: ... Lice Troopers provides full spectrum head lice screening and treatment ... including Sunset, Key Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2
... ... on How to Help the Ones We Love and Care For , ... New York City (PRWEB) July 2, 2010 ... prevention hotline has just released a free Internet guide in response to these desperate times ...
... ... grade food supplements from manufacturers with the best reputations with alternative practitioners. After more ... is expanding its inventory to include a range of health and wellness items. ... (PRWEB) July ...
... ... and liposuction system that is dependable and affordably-priced. , ... Louisville, KY (Vocus) July 2, 2010 -- DRE, ... , an affordable aspirator and liposuction system that features two positive displacement pumps and ...
... ... , ... 2010 -- The Back to School shopping season has become one of the top three ... many businesses are looking for a way to get more potential customers into their stores ...
... , ... New Chair of Board , ... Lakewood Ranch, Fla. -- ShelterBox USA, an international aid organization that provides shelter and life-saving ... the Board of Directors at the close of its fiscal year June 30, where ShelterBox ...
... ARBOR, Mich. Black people with cancer are up ... from their disease. While disparities exist for nearly every ... that benefit most from treatment -- suggesting that black ... a review from researchers at the University of Michigan ...
Cached Medicine News:Health News:Saving Lives in Desperate Times 2Health News:Saving Lives in Desperate Times 3Health News:Vitamins for Life Inventory Extended to Wellness Products, Higher Nature Supplements 2Health News:Vitamins for Life Inventory Extended to Wellness Products, Higher Nature Supplements 3Health News:DRE Introduces Economically-Priced Liposuction System 2Health News:DRE Introduces Economically-Priced Liposuction System 3Health News:Giant Crayon Sweepstakes Giveaway Helps Businesses Increase Traffic for Back to School Promotions 2Health News:ShelterBox USA Grows by 1000 Percent 2Health News:ShelterBox USA Grows by 1000 Percent 3Health News:Why are blacks more likely to die from cancer diagnosis? 2
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
Inquire...
... fixed pipette is ideal for ... volume. Fixed volume FInnpipettes offer ... as other Finnpipette Digital pipettes: ... blow-out (1-40ul), Soft-touch tip ejection, ...
Medicine Products: